Time to Treatment with Intravenous Tissue Plasminogen Activator and Outcome from Acute Ischemic Stroke in the National US GWTG-Stroke Population

被引：0
|
作者：
Saver, Jeffrey L. [1 ]
Fonarow, Gregg C. [1 ]
Smith, Eric E. [2 ]
Reeves, Mathew J. [3 ]
Grau-Sepulveda, Maria V. [4 ]
Pan, Wenqin [4 ]
Olson, DaiWai [4 ]
Hernandez, Adrian F. [4 ]
Peterson, Eric D. [4 ]
Schwamm, Lee H. [5 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Univ Calgary, Calgary, AB, Canada
[3] Michigan State Univ, E Lansing, MI 48824 USA
[4] Duke Clin Rsch Inst, Durham, NC USA
[5] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
STROKE | 2013年 / 44卷 / 02期
关键词：
Thrombolysis; Emergency care; Stroke; Fibrinolytic agents;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
    Chapman, Sherita N.
    Mehndiratta, Prachi
    Johansen, Michelle C.
    McMurry, Timothy L.
    Johnston, Karen C.
    Southerland, Andrew M.
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 75 - 87
  • [32] Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator
    Betts, Keith A.
    Hurley, Dana
    Song, Jinlin
    Sajeev, Gautam
    Guo, Jenny
    Du, Ella Xiaoyan
    Paschoalin, Marco
    Wu, Eric Q.
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (09): : 1996 - 2003
  • [33] The Effect of Age and Sex on Clinical Outcome after Intravenous Recombinant Tissue Plasminogen Activator Treatment in Patients with Acute Ischemic Stroke
    Buijs, Julie E.
    Uyttenboogaart, Maarten
    Brouns, Raf
    de Keyser, Jacques
    Kamphuisen, Pieter Willem
    Luijckx, Gert-Jan
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (02): : 312 - 316
  • [34] Additional endovascular treatment for acute ischemic stroke patients unresponsive to intravenous recombinant tissue plasminogen activator
    Hayakawa, M.
    Oomura, M.
    Sadato, A.
    Tanaka, T.
    Irie, K.
    Negoro, M.
    Kato, Y.
    Sano, H.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S85 - S85
  • [35] Sonothrombolysis: An effective adjunct to intravenous tissue plasminogen activator therapy in acute ischemic stroke
    Miyachi, Shigeru
    [J]. NEUROLOGY INDIA, 2017, 65 (01) : 20 - 21
  • [36] Combined intravenous and intraarterial tissue plasminogen activator for acute ischemic stroke: Recanalization, safety, and early clinical outcome
    Saver, JL
    Kidwell, CS
    Starkman, S
    Carneado, J
    Jahan, R
    Gobin, YP
    Duckwiler, GR
    Vespa, PM
    Villablanca, JP
    Vinuela, F
    [J]. NEUROLOGY, 2001, 56 (08) : A150 - A150
  • [37] Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years
    Mione, Gioia
    Ducrocq, Xavier
    Thilly, Nathalie
    Lacour, Jean-Christophe
    Vespignani, Herve
    Richard, Sebastien
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2016, 16 (07) : 843 - 849
  • [38] Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
    Sadeghi-Hokmabadi, Elyar
    Farhoudi, Mehdi
    Taheraghdam, Aliakbar
    Hashemilar, Mazyar
    Savadi-Osguei, Daryous
    Rikhtegar, Reza
    Mehrvar, Kaveh
    Sharifipour, Ehsan
    Youhanaee, Parisa
    Mirnour, Reshad
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2016, 9 : 361 - 367
  • [39] Quantitative electroencephalograph in acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator
    Yang, Juan
    Zhao, Xiaohui
    Bai, Qingke
    Zhao, Zhengguo
    Sui, Haijing
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (01): : 507 - 514
  • [40] The economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke
    Demaerschalk, B
    Yip, T
    [J]. STROKE, 2004, 35 (01) : 298 - 298
12345